The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL
Open accessAbstract
The (12;21) translocation resulting in TEL/AML1 gene fusion is present in about 25% of childhood precursor B-lineage acute lymphoblastic leukemia (ALL) and is associated with a good prognosis and a high cellular sensitivity to L-asparaginase (L-Asp). ALL cells are thought to be sensitive to L-Asp due to lower asparagine synthetase (AS) levels. Resistance to L-Asp may be caused by an elevated cellular level of AS or by the ability of resistant cells to rapidly induce the expression of the AS gene on L-Asp exposure. AS may be a target regulated by t(12;21). We studied the relationship between t(12;21) and the mRNA level of AS to investigate a possible mechanism underlying L-Asp sensitivity. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis surprisingly revealed that 30 patients positive for t(12;21) expressed 5-fold more AS mRNA compared with 17 patients negative for t(12;21) (P =.008) and 11 samples from healthy controls (P =.016). The mRNA levels of AS between t(12;21)(-) ALL and healthy controls did not differ. No difference was found between ALL patients positive or negative for t(12;21) in the capacity to up-regulate AS after in vitro L-Asp exposure, excluding a defective capacity for t(12;21) cells in up-regulating AS on L-Asp exposure. Moreover, no correlation was observed between AS mRNA expression and sensitivity to L-Asp. We conclude that the sensitivity of t(12;21)(+) childhood ALL to L-Asp is not associated with the expression level of the AS gene. Furthermore, we contradict the general thought that leukemic cells specifically lack AS compared with normal bone marrow and blood cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Though the mechanism of asparagine auxotrophy in ALL cells was assumed to be genetically defined, studies have shown that clinical response to L-asparaginase treatment is independent of asparagine synthase (ASNS) expression, the enzyme that converts aspartate to asparagine (Figure 7) (Appel et al., 2006; Stams et al., 2003).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Stams et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meyers, S., Downing, J. R., & Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6336 · Cited by 462
McLean, T., Ringold, S., Neuberg, D. S., Stegmaier, K., Tantravahi, R. V., Ritz, J., Koeffler, H., Takeuchi, S., Janssen, J. W. G., Seriu, T., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4252.4252 · Cited by 319
Borkhardt, A., Cazzaniga, G., Viehmann, S. F., Valsecchi, M. G., Ludwig, W. D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F. H., et al. (1997) · Blood · doi:10.1182/blood.v90.2.571 · Cited by 314
Meijerink, J. P. P., Mandigers, C. M. P. W., van de Locht, L. T., Tönnissen, E., Goodsaid, F. M., & Raemaekers, J. M. M. (2001) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60652-6 · Cited by 298
Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., van Zantwijk, C. H., Smets, L. A., van Wering, E. R., & den Berg, A. V. D. D.-V. (1997) · Blood · doi:10.1182/blood.v90.7.2723 · Cited by 272
The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
Pieters, R., Loonen, A. H., Huismans, D. R., Broekema, G., Dirven, M., Heyenbrok, M., Hählen, K., & Veerman, A. J. P. (1990) · Blood · doi:10.1182/blood.v76.11.2327.2327 · Cited by 232
Pieters, R., Huismans, D. R., Loonen, A. H., Veerman, A. J. P., Hählen, K., den Berg, A. V. D. D.-V., & Wering, E. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91029-t · Cited by 216
TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia
Seeger, K., Adams, H.-P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C. M., Ritter, J., Schwabe, D., Harms, D., Schrappe, M., et al. (1998) · Blood · doi:10.1182/blood.v91.5.1716 · Cited by 174
Harbott, J., Viehmann, S. F., Borkhardt, A., Henze, G., & Lampert, F. (1997) · Blood · doi:10.1182/blood.v90.12.4933 · Cited by 161
Cited by
Sorted by citations
Items 101–149 of 149
Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL
Stams, W. A. G., den Boer, M. L., Beverloo, H. B., van Wering, E. R., & Pieters, R. (2004) · Leukemia · doi:10.1038/sj.leu.2403573 · Cited by 15
Self-citationTong, W. H., & Rizzari, C. (2023) · Haematologica · doi:10.3324/haematol.2022.282324 · Cited by 14
Akagi, T., Yin, D., Kawamata, N., Bartram, C. R., Hofmann, W.-K., Song, J. H., Miller, C. W., den Boer, M. L., & Koeffler, H. P. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.10.022 · Cited by 14
Expression of a recombinant bacterial l-asparaginase in human cells
Dantas, R. C., Caetano, L. F., Torres, A. L. S., Alves, M. S., Silva, E. T. M. F., Teixeira, L. P. R., Teixeira, D. C., Moreira, R. D. A., Fonseca, M. H. G., Neto, S. G., et al. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4836-5 · Cited by 13
Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias
Bhingarkar, A., Vangapandu, H. V., Rathod, S., Hoshitsuki, K., & Fernandez, C. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.694526 · Cited by 11
Supramolecular assembly of GSK3α as a cellular response to amino acid starvation
Hinze, L., Schreek, S., Zeug, A., Ibrahim, N. K., Fehlhaber, B., Loxha, L., Cinar, B., Ponimaskin, E. G., Degar, J., McGuckin, C., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.025 · Cited by 12
Zhu, Y., Zhou, H., Zhu, Y., Wan, X., Zhu, J., & Zhang, T. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.640683 · Cited by 12
Zhu, Y., Zhu, Y., Yin, H., Zhou, H., Wan, X., Zhu, J., & Zhang, T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.801 · Cited by 12
Sonowal, S., Pathak, K., Das, D., Buragohain, K., Gogoi, A., Borah, N., Das, A., & Nath, R. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400156 · Cited by 11
Expression of Duffy antigen receptor for chemokines (DARC) is down-regulated in colorectal cancer
Zhou, S., Liu, M., Hu, Y., An, W., Liang, X., Yu, W., & Piao, F. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1009113 · Cited by 11
Gene expression of Hsps in normal and abnormal embryonic development of mouse hindlimbs
Yan, Z., Wei, H., Ren, C., Yuan, S., Fu, H., Lv, Y., Zhu, Y., & Zhang, T. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114555927 · Cited by 11
Zhang, X., Chen, S., Yang, L., Li, B., Zhu, K., & Li, Y. (2009) · Hematology · doi:10.1179/102453309x439755 · Cited by 10
Zhang, X. L., Li, Y., Chen, S. H., YANG, L. J., CHEN, S., Wu, X., Zhang, T.-S., Zhong, J., & ZHU, K. E. (2008) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2008.01091.x · Cited by 10
Pui, C. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.017 · Cited by 9
Molecular Pharmacodynamics in Childhood Leukemia
Pieters, R., & den Boer, M. L. (2003) · International Journal of Hematology · doi:10.1007/bf02983812 · Cited by 7
Chen, S., Yang, L., Lu, X., Li, B., Chan, J. Y.-H., Cai, D., & Li, Y. (2010) · Hematology · doi:10.1179/102453309x12583347113537 · Cited by 7
Evaluation of the Asparagine Synthetase Level in Leukemia Cells by Monoclonal Antibodies
Kusano‐Arai, O., Iwanari, H., Mochizuki, Y., Nakata, H., Kodama, T., Kitoh, T., & Hamakubo, T. (2012) · Hybridoma · doi:10.1089/hyb.2012.0014 · Cited by 6
Loxha, L., Ibrahim, N. K., Stasche, A. S., Cinar, B., Dolgner, T., Niessen, J., Schreek, S., Fehlhaber, B., Forster, M., Stanulla, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713260 · Cited by 5
Wrona, E., Jakubowska, J., Pawlik, B., Pastorczak, A. K., Madzio, J., Lejman, M., Sędek, Ł., Kowalczyk, J., Szczepański, T., & Mlynarski, W. M. (2019) · Oncology Letters · doi:10.3892/ol.2019.11046 · Cited by 5
Lee, J. K., Kamran, H., & Lee, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02142-9 · Cited by 4
Hurteau, G. J., Broome, J. D., & Brock, G. (2005) · Leukemia · doi:10.1038/sj.leu.2403969 · Cited by 4
The expression pattern of CD3 chain genes in fetal/maternal interface
Lu, X., Chen, S., Yang, L., Zha, X., Yang, X., & Li, Y. (2011) · Hematology · doi:10.1179/102453311x12953015767419 · Cited by 4
Kong, X., Zheng, J., Liu, X., Wang, W., Jiang, X., Chen, J., Lai, J., Jin, Z., & Wu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823352 · Cited by 4
Holcenberg, J. S. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000166918.29879.65 · Cited by 4
Cancer Therapies Targeting Cellular MetabolismPreprint
Morris, B. L., & Gutiérrez, A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041657 · Cited by 5
Biochemical Markers of Tumor Cell Sensitivity to L-Asparaginase
Kislyak, I. A., & Pokrovsky, V. S. (2023) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750823600541 · Cited by 3
RNAi of Grp78 may disturb the fusion of ICR mouse palate cultured in vitro
Ren, C., Li, X., Li, X., Xie, Y., Fu, H., Yan, Z., & Zhu, Y. (2017) · Human & Experimental Toxicology · doi:10.1177/0960327117692132 · Cited by 3
Mechanistic insights into L-asparaginase resistance in cancers
Deng, L., Zhou, J., Liu, Y., & Cui, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112317 · Cited by 1
Genetics and cellular drug resistance in acute leukemia
den Boer, M. L., & Pieters, R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.011 · Cited by 1
Mulatsih, S., Sunarto, S., & Sutaryo, S. (2016) · Sari Pediatri · doi:10.14238/sp10.6.2009.404-9 · Cited by 1
Zhang, X., Yuping, Z., Tian, Y., Yan, H., Ren, L., Shi, W., Jiangbo, Z., & Zhang, T. (2018) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1458237 · Cited by 1
Stams, W. A. G., den Boer, M. L., Beverloo, H. B., van Wering, E. R., & Pieters, R. (2004) · Leukemia · doi:10.1038/sj.leu.2403576 · Cited by 1
Self-citationMining Gene Sets for Measuring Similarities
Nardini, C., Masotti, D., Yoon, S., Macii, E., Kuo, M. D., Micheli, G. D., & Luca Benini, C. (2006) · IEEE Symposium on Computers and Communications (ISCC) · doi:10.1109/iscc.2006.101 · Cited by 1
Produção de L-asparaginase extracelular por fermentação em estado sólido
Cachumba, J. J. M. (2017) · doi:10.11606/d.97.2017.tde-30062017-200104 · Cited by 1
Novel genomic determinants of apoptotic defects in acute lymphoblastic leukemia
de Haar-Holleman, A. (2006) · RePub (Erasmus University Rotterdam)
Hernández‐Maraver, D., Colldeforns, J. G., Rodrguez, T. C., & Navarro, F. H. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70202-7
Czynniki warunkujące aktywność terapeutyczną L-asparaginazy
Walenciak, J., & Zalewska‐Szewczyk, B. (2013) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2013.09.001
Molecular mechanisms of glucocorticoid resistance in childhood acute lymphoblastic leukemia
Tissing, W. J. E. (2006) · RePub (Erasmus University Rotterdam)
XVI CICLO DEL DOTTORATO DI RICERCA IN
Riproduzione, S. D. (2013)
Assays and molecular determinants of cellular drug resistance
den Boer, M. L., & Pieters, R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.016
血液・腫瘍疾患における L-asparaginase の有効性
鬼頭, 敏. (2003) · 日本小児血液学会雑誌 · doi:10.11412/jjph1987.17.449
Epigenetics changes affecting L-asparaginase therapy in human leukemia: a mini review
Moosavi, S., Mohammadi, M., & Lagzian, M. (2021) · Medbiotech Journal · doi:10.22034/mbt.2021.135218
Lorenzi, P. L., Llamas, J., Gunsior, M., Ozbun, L. L., Reinhold, W. C., Varma, S., Ji, H., Kim, H., Hutchinson, A. A., Kohn, E. C., et al. (2023) · doi:10.1158/1535-7163.c.6531095
Lorenzi, P. L., Llamas, J., Gunsior, M., Ozbun, L. L., Reinhold, W. C., Varma, S., Ji, H., Kim, H., Hutchinson, A. A., Kohn, E. C., et al. (2023) · doi:10.1158/1535-7163.c.6531095.v1
Biology of cancer: current insights and perspectives
Hakkimane, S. S., & Gaonkar, S. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16034-9.00011-3
Lefeivre, T., Tudose, C., Grosu, T.-I., Jones, L., León, T. E., Wynne, K. J., Oliviero, G., Smith, O. P., Trinquand, A., Mansour, M. R., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2024015408
Biología y tratamiento de la leucemia linfoblástica aguda
Pieters, R., & Carroll, W. L. (2008) · Clínicas pediátricas de Norteamérica
Metadata
- Authors
- Stams, W. A. G.
- Affiliations
- Erasmus MC (NL)
- Corresponding author
- Stams, W. A. G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-11-14
- Volume
- 101
- Issue
- 7
- Pages
- 2743-2747
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2149324701
- Cited by
- 149
- References
- 35
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 6 · 2012: 11
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- L-asparaginase, asparagine synthetase, TEL-AML1 fusion, childhood acute lymphoblastic leukemia, B-lineage ALL, drug sensitivity, gene expression, chemoresistance
- MeSH terms
- Asparaginase, Aspartate-Ammonia Ligase, Child, Child, Preschool, Chromosomes, Human, Pair 12, Chromosomes, Human, Pair 21, Humans, Infant, RNA, Messenger, Translocation, Genetic, Leukemia, Lymphocytic, Chronic, B-Cell, Up-Regulation, Case-Control Studies, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
